Regeneron (REGN) is a publicly traded Healthcare sector company. As of October 1, 2026, REGN trades at $756.50 with a market cap of $77.27B and a P/E ratio of 18.10. REGN moved +1.01% today. Year to date, REGN is -2.32%; over the trailing twelve months it is +34.86%. Its 52-week range spans $476.49 to $859.34. Analyst consensus is buy with an average price target of $839.10. Rallies surfaces REGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks REGN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $756.50 |
| Market Cap | $77.27B |
| P/E Ratio | 18.10 |
| EPS | $41.94 |
| Dividend Yield | 0.94% |
| 52-Week High | $859.34 |
| 52-Week Low | $476.49 |
| Volume | 598.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $15.53B |
| Net Income | $4.33B |
| Gross Margin | 0.00% |
20 analysts cover REGN: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $839.10.